Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells ...
Through his public-benefit corporation Star Syringe, Koska first needed to embark on a public policy and advocacy campaign to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback